Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2013
12/17/2013CA2492598C Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
12/17/2013CA2478855C Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/17/2013CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4
12/17/2013CA2410883C Methods for isolating and using fungal hemolysins
12/17/2013CA2395423C P. gingivalis antigenic composition
12/17/2013CA2370563C Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
12/17/2013CA2366921C Novel cytokine zalpha11 ligand
12/17/2013CA2232813C Transgenic non-human animals capable of producing heterologous antibodies
12/12/2013WO2013185114A2 Chimeric clotting factors
12/12/2013WO2013185113A1 Procoagulant compounds
12/12/2013WO2013185108A1 Methods and products related to lung cancer
12/12/2013WO2013185097A1 Ultrasound-triggerable agents for tissue engineering
12/12/2013WO2013185003A1 Methods for increasing insulin sensitivity and treating diabetes with a bioactive chromium binding peptide
12/12/2013WO2013184986A2 Methods and compositions for inhibiting angiogenesis
12/12/2013WO2013184962A1 Chimeric fibroblast growth factor 19 proteins and methods of use
12/12/2013WO2013184960A2 Chimeric fibroblast growth factor 23 proteins and methods of use
12/12/2013WO2013184958A1 Chimeric fibroblast growth factor 21 proteins and methods of use
12/12/2013WO2013184915A1 Hydrogels for delivery of therapeutic polypeptides
12/12/2013WO2013184824A1 Methods for treating psychiatric disorders or symptoms thereof using ncam peptide mimetics
12/12/2013WO2013184646A2 Dosing regimens for subcutaneously infusible acidic compositions
12/12/2013WO2013184614A2 Peptide conjugates for treating pain
12/12/2013WO2013184482A1 Method of treating and preventing ocular angiogenesis
12/12/2013WO2013184216A1 Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
12/12/2013WO2013184209A1 Mif for use in methods of treating subjects with a neurodegenerative disorder
12/12/2013WO2013184024A1 Preparation for increasing sperm production in stud livestock and roosters and method for the use thereof
12/12/2013WO2013183494A1 Therapeutic agent, treatment method and test method for diseases associated with activation of neutrophils
12/12/2013WO2013183052A1 Pegylated oxm variants
12/12/2013WO2013182905A2 Mechanism, diagnostic, and treatments for complications of renal failure
12/12/2013WO2013182806A1 Annelid haemoglobin lyophilisation process
12/12/2013WO2013182653A1 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
12/12/2013WO2013182652A1 Allosteric chaperones and uses thereof
12/12/2013WO2013182650A1 Method and pharmaceutical composition for use in the treatment of cancer
12/12/2013WO2013181934A1 Polypeptide with function of synergistic targeted diagnosis and therapy of nasopharyngeal carcinoma, nanoparticles carrying same and use thereof
12/12/2013WO2013181755A1 Human tissue kallikrein 1 glycosylation isoforms
12/12/2013WO2013181696A1 Vaccination with interleukin-4 antagonists
12/12/2013WO2013156031A3 SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT
12/12/2013WO2013154647A3 Il-12 for radiation protection and radiation-induced toxicity mitigation
12/12/2013WO2013118128A3 Cellular apobec3 proteins and modulators thereof for reglulating dna repair processes and treating proliferative diseases
12/12/2013US20130333059 Hox compositions and methods
12/12/2013US20130331546 Annexin ii compositions and methods
12/12/2013US20130331344 Learning motivation improvers
12/12/2013US20130331343 Materials Presenting Notch Signaling Molecules To Control Cell Behavior
12/12/2013US20130331341 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331340 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331339 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331338 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331337 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331336 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331331 Hexapeptide with improved activity in the repair of cellular dna of dermal cells
12/12/2013US20130331330 Methods of treating alzheimer's disease and other tauopathies with inhibitors of microtubule affinity regulating kinase
12/12/2013US20130331329 Biomarkers for seizures
12/12/2013US20130331328 Small molecule inhibitors of agbl2
12/12/2013US20130331327 Variant Beta2-microglobulin, characterization of the same and applications thereof
12/12/2013US20130331326 Method of inducing hematopoietic reconstruction
12/12/2013US20130331325 Chimeric fibroblast growth factor 23 proteins and methods of use
12/12/2013US20130331324 Use of melanocortins to treat dyslipidemia
12/12/2013US20130331323 Glp-1 potentiators from hedychium coronarium and their applications
12/12/2013US20130331322 Exendins and exendin agonist analogs to regulate gastrointestinal motility
12/12/2013US20130331320 Fast-acting insulin in combination with long-acting insulin
12/12/2013US20130331319 Methods of delivering stable topical drug compositions
12/12/2013US20130331318 Methods of delivering stable topical drug compositions
12/12/2013US20130331317 Chimeric fibroblast growth factor 19 proteins and methods of use
12/12/2013US20130331316 Chimeric fibroblast growth factor 21 proteins and methods of use
12/12/2013US20130331314 Pharmaceutical composition for treating hcv infections
12/12/2013US20130331313 Methods and compositions for treating viral or virally-induced conditions
12/12/2013US20130331312 Medicinal composition containing echinocandin antifungal agent micafungin and preparation method and use thereof
12/12/2013US20130331311 Synergistic Combinations of Polyene Fungicides and Non-Ribosomal Peptides and Related Methods of Use
12/12/2013US20130331310 Prodrug of an Ice Inhibitor
12/12/2013US20130330422 Methods for increasing insulin sensitivity and treating diabetes with a bioactive chromium binding peptide
12/12/2013US20130330421 Combinations of therapeutic agents for treating melanoma
12/12/2013US20130330411 Pharmaceutical cyclosporin compositions
12/12/2013US20130330381 Methods of delivering stable topical drug compositions
12/12/2013US20130330380 Topical drug delivery using phosphatidylcholine
12/12/2013US20130330376 Test of insulin as a drug to reduce restenosis of vessels
12/12/2013US20130330358 Crystal structure and peptide inhibitors of hausp deubiquitinase
12/12/2013US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013US20130330335 Bioinformatic processes for determination of peptide binding
12/12/2013US20130330333 Treatment of angiogenesis disorders
12/12/2013US20130330329 B7-h7 antibodies and method of use
12/12/2013US20130330326 Methods of treating cancer
12/12/2013US20130330320 Methods for Treating Adhesive Capsulitis
12/12/2013US20130330318 Method for Treating Filtration Failure After Trabeculectomy Surgery
12/12/2013US20130330317 Methods for Treating Lysosomal Acid Lipase Deficiency
12/12/2013US20130330315 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase
12/12/2013US20130330313 Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes
12/12/2013US20130330309 Nutraceutical and pharmaceutical composition
12/12/2013US20130330308 Feed additive composition
12/12/2013US20130330302 Retinal pigment epithelial stem cells
12/12/2013US20130330301 Enhanced Medical Implant
12/12/2013US20130330297 Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
12/12/2013US20130330294 Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy
12/12/2013DE112012001046T5 Stabile kolloidale Goldnanopartikel mit kontrollierbarer Oberflächenmodifizierung und Funktionalisierung Stable colloidal gold nanoparticles with controllable surface modification and functionalization
12/12/2013CA2876135A1 Modified fibronectin fragments or variants and uses thereof
12/12/2013CA2875980A1 Binding agents that modulate the hippo pathway and uses thereof
12/12/2013CA2875827A1 Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
12/12/2013CA2875790A1 Chimeric fibroblast growth factor 21 proteins and methods of use
12/12/2013CA2875683A1 Vaccination with interleukin-4 antagonists
12/12/2013CA2875674A1 Methods for treating psychiatric disorders or symptoms thereof using ncam peptide mimetics
12/12/2013CA2875599A1 Pegylated oxm variants
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 3163